Description：Rabbit polyclonal antibody to Laminin ReceptorImmunogen：KLH-conjugated synthetic peptide encompassing a sequence within the center region of human Laminin Receptor. The exact sequence is proprietary.Purification：The antibody was purified by immunogen affinity chromatography.Clonality：PolyclonalForm：Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.Dilution：WB (1/500 - 1/1000), IH (1/100 - 1/200)Gene Symbol：RPSAAlternative Names：LAMBR; LAMR1; 40S ribosomal protein SA; 37 kDa laminin receptor precursor; 37LRP; 37/67 kDa laminin receptor; LRP/LR; 67 kDa laminin receptor; 67LR; Colon carcinoma laminin-binding protein; Laminin receptor 1; LamR; Laminin-binding protein precursor p40; LBP/p40; Multidrug resistance-associated protein MGr1-Ag; NEM/1CHD4 Entrez Gene (Human)： 3921; Entrez Gene (Mouse)： 102642689; 16785; Entrez Gene (Rat)： 29236; SwissProt (Human)： P08865; SwissProt (Mouse)： P14206; SwissProt (Rat)： P38983; Storage/Stability：Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.

• 
  Western blot analysis of Laminin Receptor expression in K562 (A) whole cell lysates. (Predicted band size: 32 kD; Observed band size: 43 kD)
• 
  Immunohistochemical analysis of Laminin Receptor staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.